What evidence do we need for biomarker qualification?
Year: 2017
Type: article
Source: Science Translational Medicine
Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, Foundation for the National Institutes of Health, Pfizer (United States), National Institutes of Health, National Institute of Mental Health, Critical Path Institute, Pharmaceutical Research and Manufacturers of America, National Cancer Institute, Massachusetts General Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States), Genentech
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2768386871
